Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Electro-acupuncture stimulation improves spontaneous locomotor hyperactivity in MPTP intoxicated mice.

Wang H, Liang X, Wang X, Luo D, Jia J, Wang X.

PLoS One. 2013 May 30;8(5):e64403. doi: 10.1371/journal.pone.0064403.

2.

The antioxidative effect of electro-acupuncture in a mouse model of Parkinson's disease.

Wang H, Pan Y, Xue B, Wang X, Zhao F, Jia J, Liang X, Wang X.

PLoS One. 2011;6(5):e19790. doi: 10.1371/journal.pone.0019790.

3.

Neuroprotection effects of retained acupuncture in neurotoxin-induced Parkinson's disease mice.

Yang JL, Chen JS, Yang YF, Chen JC, Lin CH, Chang RS, Tsao PJ, Chen FP, Chern CM, Tsai TH, Chiu JH.

Brain Behav Immun. 2011 Oct;25(7):1452-9. doi: 10.1016/j.bbi.2011.05.012.

PMID:
21669281
4.

Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Schumm S, Sebban C, Cohen-Salmon C, Callebert J, Launay JM, Golmard JL, Boussicault L, Petropoulos I, Hild A, Rousselet E, Prigent A, Friguet B, Mariani J, Hirsch EC.

J Neurochem. 2012 Sep;122(5):1032-46. doi: 10.1111/j.1471-4159.2012.07837.x.

5.

Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.

Petzinger GM, Walsh JP, Akopian G, Hogg E, Abernathy A, Arevalo P, Turnquist P, Vucković M, Fisher BE, Togasaki DM, Jakowec MW.

J Neurosci. 2007 May 16;27(20):5291-300.

8.

CDNF protects the nigrostriatal dopamine system and promotes recovery after MPTP treatment in mice.

Airavaara M, Harvey BK, Voutilainen MH, Shen H, Chou J, Lindholm P, Lindahl M, Tuominen RK, Saarma M, Hoffer B, Wang Y.

Cell Transplant. 2012;21(6):1213-23. doi: 10.3727/096368911X600948.

9.

The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.

Shepherd KR, Lee ES, Schmued L, Jiao Y, Ali SF, Oriaku ET, Lamango NS, Soliman KF, Charlton CG.

Pharmacol Biochem Behav. 2006 Mar;83(3):349-59.

PMID:
16580056
10.

Post-MPTP treatment with granulocyte colony-stimulating factor improves nigrostriatal function in the mouse model of Parkinson's disease.

McCollum M, Ma Z, Cohen E, Leon R, Tao R, Wu JY, Maharaj D, Wei J.

Mol Neurobiol. 2010 Jun;41(2-3):410-9. doi: 10.1007/s12035-010-8118-4.

PMID:
20405343
11.

Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

L'Episcopo F, Tirolo C, Caniglia S, Testa N, Serra PA, Impagnatiello F, Morale MC, Marchetti B.

J Neuroinflammation. 2010 Nov 23;7:83. doi: 10.1186/1742-2094-7-83.

12.

Influence of noradrenaline denervation on MPTP-induced deficits in mice.

Archer T, Fredriksson A.

J Neural Transm (Vienna). 2006 Sep;113(9):1119-29.

PMID:
16362627
13.

Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.

Ghosh A, Kanthasamy A, Joseph J, Anantharam V, Srivastava P, Dranka BP, Kalyanaraman B, Kanthasamy AG.

J Neuroinflammation. 2012 Oct 23;9:241. doi: 10.1186/1742-2094-9-241.

14.

Chronic MPTP treatment produces hyperactivity in male mice which is not alleviated by concurrent trehalose treatment.

Ferguson SA, Law CD, Sarkar S.

Behav Brain Res. 2015 Oct 1;292:68-78. doi: 10.1016/j.bbr.2015.05.057.

PMID:
26111725
15.

Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease.

Luchtman DW, Shao D, Song C.

Physiol Behav. 2009 Aug 4;98(1-2):130-8. doi: 10.1016/j.physbeh.2009.04.021.

PMID:
19410592
16.

Influences of Chronic Mild Stress Exposure on Motor, Non-Motor Impairments and Neurochemical Variables in Specific Brain Areas of MPTP/Probenecid Induced Neurotoxicity in Mice.

Janakiraman U, Manivasagam T, Thenmozhi AJ, Essa MM, Barathidasan R, SaravanaBabu C, Guillemin GJ, Khan MA.

PLoS One. 2016 Jan 14;11(1):e0146671. doi: 10.1371/journal.pone.0146671.

17.

Neuroprotective effects of caffeine in MPTP model of Parkinson's disease: A (13)C NMR study.

Bagga P, Chugani AN, Patel AB.

Neurochem Int. 2016 Jan;92:25-34. doi: 10.1016/j.neuint.2015.11.006.

PMID:
26626997
18.

The effect of electroaucpuncture for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced proteomic changes in the mouse striatum.

Kim ST, Moon W, Chae Y, Kim YJ, Lee H, Park HJ.

J Physiol Sci. 2010 Jan;60(1):27-34. doi: 10.1007/s12576-009-0061-7.

PMID:
19760485
19.

Murine motor and behavior functional evaluations for acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication.

Hutter-Saunders JA, Gendelman HE, Mosley RL.

J Neuroimmune Pharmacol. 2012 Mar;7(1):279-88. doi: 10.1007/s11481-011-9269-4.

20.

Nrf2-ARE signals mediated the anti-oxidative action of electroacupuncture in an MPTP mouse model of Parkinson's disease.

Lv E, Deng J, Yu Y, Wang Y, Gong X, Jia J, Wang X.

Free Radic Res. 2015;49(11):1296-307. doi: 10.3109/10715762.2015.1067696.

PMID:
26118717

Supplemental Content

Support Center